- Home
- QURE vs WLKP Comparison
QURE vs WLKP Comparison
Compare QURE & WLKP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QURE
- WLKP
- Stock Information
- Founded
- QURE 1998
- WLKP 2014
- Country
- QURE Netherlands
- WLKP United States
- Employees
- QURE N/A
- WLKP N/A
- Industry
- QURE Biotechnology: Pharmaceutical Preparations
- WLKP Major Chemicals
- Sector
- QURE Health Care
- WLKP Industrials
- Exchange
- QURE Nasdaq
- WLKP Nasdaq
- Market Cap
- QURE 725.4M
- WLKP 795.0M
- IPO Year
- QURE 2007
- WLKP 2014
- Fundamental
- Price
- QURE $15.21
- WLKP $22.02
- Analyst Decision
- QURE Strong Buy
- WLKP
- Analyst Count
- QURE 10
- WLKP 0
- Target Price
- QURE $37.20
- WLKP N/A
- AVG Volume (30 Days)
- QURE 1.0M
- WLKP 31.0K
- Earning Date
- QURE 07-29-2025
- WLKP 08-05-2025
- Dividend Yield
- QURE N/A
- WLKP 8.56%
- EPS Growth
- QURE N/A
- WLKP N/A
- EPS
- QURE N/A
- WLKP 1.49
- Revenue
- QURE $20,201,000.00
- WLKP $1,088,852,000.00
- Revenue This Year
- QURE N/A
- WLKP $8.90
- Revenue Next Year
- QURE $278.91
- WLKP $6.87
- P/E Ratio
- QURE N/A
- WLKP $14.78
- Revenue Growth
- QURE 6.30
- WLKP N/A
- 52 Week Low
- QURE $4.45
- WLKP $21.19
- 52 Week High
- QURE $19.18
- WLKP $25.04
- Technical
- Relative Strength Index (RSI)
- QURE 55.32
- WLKP 42.45
- Support Level
- QURE $13.61
- WLKP $21.92
- Resistance Level
- QURE $15.49
- WLKP $22.40
- Average True Range (ATR)
- QURE 0.81
- WLKP 0.29
- MACD
- QURE 0.08
- WLKP -0.01
- Stochastic Oscillator
- QURE 72.65
- WLKP 14.29
About QURE uniQure N.V.
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.
About WLKP Westlake Chemical Partners LP Common Units representing limited partner interests
Westlake Chemical Partners LP is a part of the chemical industry in the United States. Its operations are conducted through OpCo, it acquires and develops ethylene production facilities, which convert ethane into ethylene. OpCo sells ethylene and its co-products such as propylene, crude butadiene, pyrolysis gasoline, and hydrogen to Westlake and other customers located in the United States. Its assets include three ethylene production facilities in Calvert City, Kentucky, and Lake Charles, Louisiana.